Results 121 to 130 of about 8,840 (216)

Serum SERPINA3 as a Candidate Non-Invasive Biomarker for Neuromyelitis Optica Spectrum Disorder: Proteomic Discovery and Same-Center Validation. [PDF]

Diagnostics (Basel)
Xu T, Han B, Zheng G, Jiang W, Zhang H, Zhang G.   +5 more
europepmc   +1 more source

NMOSD and MOGAD Dual Positivity

Annals of Indian Academy of Neurology, 2022
Ayush Agarwal, Aminu Aliyar, Shilpa Rao, Anita Mahadevan, Ajay Garg, Achal Srivastava   +5 more
openaire   +3 more sources

Intractable hiccups as a brainstem red flag: demyelinating disorders with emphasis on neuromyelitis optica spectrum disorder and area postrema syndrome. [PDF]

Neurol Sci
Eliaçık S.
europepmc   +1 more source

Primary Central Nervous System Histiocytic Sarcoma During Neuromyelitis Optica Spectrum Disorder. [PDF]

J Clin Neurol
Saito-Sato N, Bae Y, Hashida H.
europepmc   +1 more source

Roles of cerebrospinal fluid metabolites in neuromyelitis optica spectrum disorder: Insights from Mendelian randomization. [PDF]

Medicine (Baltimore)
Deng L, Ling S, Li L, Li Q, Ye Q, Liu X, Ren Z.   +6 more
europepmc   +1 more source

OCTA-derived retinal microvascular biomarkers in neuromyelitis optica spectrum disorder: clinical potential, methodological challenges, and possible links to astrocytopathy. [PDF]

Front Med (Lausanne)
Amaxilati E, Bakirtzis C, Fountouki A, Koutsiouki C, Pirounides D.   +4 more
europepmc   +1 more source

Risk of Peripheral Artery Disease and Venous Thromboembolism in Patients with Neuromyelitis Optic Spectrum Disorder: A Nationwide Population-Based Cohort Study. [PDF]

Int J Med Sci
Chen XA, Wu CN, Tsai TH, Lin CY, Chang H, Gau SY, Huang KH, Lee CY.   +7 more
europepmc   +1 more source

Global trends and emerging hotspots in neuromyelitis optica spectrum disorder diagnostic research: A bibliometric analysis. [PDF]

Medicine (Baltimore)
Lei S, Zhang Y, Wang Y.
europepmc   +1 more source

Use of Fluid Biomarkers in NMOSD and MOGAD: Clinical and Research Applications. [PDF]

Neurol Neuroimmunol Neuroinflamm
Mariotto S, Cobo-Calvo A, Khalil M, Armangue T, Aktas O, Höftberger R, Neuteboom RF, Pröbstel AK, Reindl M, Waters PJ, Arrambide G, Paul F, Palace J, Marignier R, Hacohen Y, as the MEDEN (MOGAD Eugène Devic European Network) Steering Committee.   +15 more
europepmc   +1 more source

Complement C3 inhibitory peptide AMY-101 ameliorates brain injury in a mouse model of NMOSD. [PDF]

Ann Med
Zhu W, He F, Meng F, Wei R, Liang H.
europepmc   +1 more source